HOME › DRUGS › ANIFROLUMAB-FNIA
ACTIVE SUBSTANCE / INN

ANIFROLUMAB-FNIA

Brand name(s): SAPHNELO
FDA LISTED
PRESCRIPTION
BLA761123
ACTIVE SUBSTANCE
Anifrolumab-Fnia
REGULATORS
FDA
SPONSORS / MAH
ASTRAZENECA AB
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SAPHNELOBLA761123ASTRAZENECA ABPrescription

FULL INTELLIGENCE ON ANIFROLUMAB-FNIA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →